IFN production ability and healthy ageing: Mixed model analysis of a 24 year longitudinal study in Japan

BMJ Open

Volumn 3, Issue 1, 2013, Pages

  Uno, Kazuko ^a   Yagi, Katsumi ^a   Yoshimori, Masayo ^b   Tanigawa, Mari ^a   Yoshikawa, Toshikazu ^a   Fujita, Setsuya ^a  

^a Louis Pasteur Center for Medical Research   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; COHORT ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; JAPAN; LONGITUDINAL STUDY; MALE; MEDICAL EXAMINATION; NORMAL HUMAN;

EID: 84873420504     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002113     Document Type: Article

References (37)

1. Larbi A, Franceschi C, Mazzatti D, et al. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 2008;23:64-74.
2. Weinberger B, Herndler-Brandstetter D, Schwanninger A, et al. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008;46:1078-84. (Pubitemid 351589876)
3. Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal 2011;14:1551-85.
4. Hirokawa K, Utsuyama M, Kasai M, et al. Aging and immunity. Acta Pathol Jpn 1992;42:537-48.
5. Fulop T, Larbi A, Wikby A, et al. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drug Aging 2005;22:589-603. (Pubitemid 41214552)
6. Herndler-Brandstetter D, Cioca DP, Grubeck-Loebenstein B. Immunizations in the elderly: do they live up to their promise? Wien Med Wochenschr (1946) 2006;156:130-41.
7. Kovaiou RD, Grubeck-Loebenstein B. Age-associated changes within CD4+ T cells. Immunol Lett 2006;107:8-14. (Pubitemid 44332549)
8. Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 2009;21:440-5.
9. Franceschi C, Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Transact 2003;31:457-61. (Pubitemid 36520700)
10. Bella S Della, Bierti L, Presicce P, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007;122:220-8. (Pubitemid 46073895)
11. Alonso-Fernandez P, Puerto M, Mate I, et al. Neutrophils of centenarians show function levels similar to those of young adults. J Am Geriatr Soc 2008;56:2244-51.
12. Wikby A, Maxson P, Olsson J, et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998;102:187-98. (Pubitemid 28353538)
13. Pawelec G, Derhovanessian E. Role of CMV in immune senescence. Virus Res 2011;157:175-9.
14. Baron S. The biological significance of the interferon system. Arch Intern Med 1970;126:84-93.
15. Le Bon A, Schiavoni G, D'Agostino G, et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001;14:461-70. (Pubitemid 32441598)
16. Santini SM, Di Pucchio T, Lapenta C, et al. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J Interferon Cytokine Res 2002;22:1071-80. (Pubitemid 36051179)
17. Gabriele L, Borghi P, Rozera C, et al. IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment. Blood 2004;103:980-7. (Pubitemid 38129560)
18. Rizza P, Moretti F, Belardelli F. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity. Autoimmunity 2010;43:204-9.
19. Belardelli F, Ferrantini M, Proietti E, et al. Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 2002;13:119-34. (Pubitemid 34229387)
20. Jouanguy E, Altare F, Lamhamedi-Cherradi S, et al. Infections in IFNGR-1-deficient children. J Interferon Cytokine Res 1997;17:583-7. (Pubitemid 27451154)
21. Jouanguy E, Zhang SY, Chapgier A, et al. Human primary immunodeficiencies of type I interferons. Biochimie 2007;89:878-83. (Pubitemid 47001646)
22. Uno K, Nakano K, Maruo N, et al. Determination of interferon-alpha- producing capacity in whole blood cultures from patients with various diseases and from healthy persons. J Interferon Cytokine Res 1996;16:911-18. (Pubitemid 26400683)
23. Shirakawa K, Muso E, Nogaki F, et al. Correlation between the severity of clinicopathological parameters and whole blood interferon-alpha production capacity in active phase IgA nephropathy patients. Nephron 2002;90:24-30. (Pubitemid 34042837)
24. Uno K, Suginoshita Y, Kakimi K, et al. Impairment of IFN-alpha production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma. World J Gastroenterol 2005;11:7330-4. (Pubitemid 43137685)
25. Uno K, Hirosaki M, Kakimi K, et al. Impaired IFN-alpha production and the risk of cancer development. J Interferon Cytokine Res 2007;27:1013-17.
26. Tominaga M, Uno K, Yagi K, et al. Association between capacity of interferon-alpha production and metabolic parameters. J Interferon Cytokine Res 2010;30:451-4.
27. Nilsson B-O, Ernerudh J, Johansson B, et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev 2003;124:469-76. (Pubitemid 36514902)
28. O'Brien RJ, Resnick SM, Zonderman AB, et al. Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis: JAD 2009;18:665-75.
29. Doi Y, Ninomiya T, Hata J, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010;41:203-9.
30. Iida M, Ikeda F, Ninomiya T, et al. White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study. Am J Epidemiol 2012;175:504-10.
31. Sridharan A, Esposo M, Kaushal K, et al. Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age (Dordrecht, Netherlands) 2011;33:363-76.
32. Caruso C, Lio D, Cavallone L, et al. Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci 2004;1028:1-13. (Pubitemid 40361805)
33. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000;908:244-54. (Pubitemid 30462008)
34. Kuriyama S, Nakaya N, Ohmori-Matsuda K, et al. The Ohsaki Cohort 2006 Study: design of study and profile of participants at baseline. J Epidemiol/Jpn Epidemiol Assoc 2010;20:253-8.
35. Ekerdt DJ, Bosse R, Lo Castro JS. Claims that retirement improves health. J Gerontol 1983;38:231-6. (Pubitemid 13112301)
36. Sjosten N, Nabi H, Westerlund H, et al. Influence of retirement and work stress on headache prevalence: a longitudinal modelling study from the GAZEL Cohort Study. Cephalalgia 2011;31:696-705.
37. Westerlund H, Vahtera J, Ferrie JE, et al. Effect of retirement on major chronic conditions and fatigue: French GAZEL occupational cohort study. BMJ 2010;341:c6149.